U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07096934) titled 'Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care' on July 09.
Brief Summary: This is a prospective, multicentre, randomized clinical trial evaluating the safety, tolerability, and efficacy of up to 12 weeks treatment with SoC + low- or high-dose CYWC628 in treating DFU, compared to SoC only.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Diabetic Foot Ulcer (DFU)
Intervention:
OTHER: Standard of Care (SOC)
The participant's DFU will be sharply debrided (as needed), dressed ...